Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debbie L Shawcross

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Metabolic Brain Disease|August 30, 2024
Infection, inflammation and hepatic encephalopathy from a clinical perspectiveYevedzo Ntuli, Debbie L Shawcross
United European Gastroenterology Journal|January 5, 2024
The assessment and management of cirrhotic patients with encephalopathyH Kibble, Debbie L Shawcross
Neurochemistry International|November 10, 2011
The neurological manifestations of acute liver failureDebbie L Shawcross, Julia A Wendon
Alimentary Pharmacology & Therapeutics|July 6, 2024
Editorial: Sounding the alarm-The rising global burden of adolescent and young adult alcohol-related liver diseaseVictoria T Kronsten, Debbie L Shawcross
Current Opinion in Critical Care|April 5, 2008
Outcome of patients with cirrhosis admitted to intensive careMark J Austin, Debbie L Shawcross
The American Journal of Gastroenterology|August 28, 2024
Clinical Implications of Inflammation in Patients With CirrhosisVictoria T Kronsten, Debbie L Shawcross
Expert Review of Gastroenterology & Hepatology|November 19, 2013
Recent insights into the pathogenesis of hepatic encephalopathy and treatmentsJonathan P Sturgeon, Debbie L Shawcross
Hepatology (Baltimore, Md.)|May 23, 2015
Salivary microbiota-immune profiling in cirrhosis: could this be the noninvasive strategy that will revolutionize prognostication in hepatology?Vishal C Patel, Debbie L Shawcross
Lancet (London, England)|July 27, 2010
The 6-month abstinence rule in liver transplantationDebbie L Shawcross, John G O'Grady
Hepatology (Baltimore, Md.)|January 7, 2022
The rise and fall and rise again of ammonia as a therapeutic target in HEThomas H Tranah, Debbie L Shawcross
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Metabolic Brain Disease|August 30, 2024
Infection, inflammation and hepatic encephalopathy from a clinical perspectiveYevedzo Ntuli, Debbie L Shawcross
United European Gastroenterology Journal|January 5, 2024
The assessment and management of cirrhotic patients with encephalopathyH Kibble, Debbie L Shawcross
Neurochemistry International|November 10, 2011
The neurological manifestations of acute liver failureDebbie L Shawcross, Julia A Wendon
Alimentary Pharmacology & Therapeutics|July 6, 2024
Editorial: Sounding the alarm-The rising global burden of adolescent and young adult alcohol-related liver diseaseVictoria T Kronsten, Debbie L Shawcross
Current Opinion in Critical Care|April 5, 2008
Outcome of patients with cirrhosis admitted to intensive careMark J Austin, Debbie L Shawcross
The American Journal of Gastroenterology|August 28, 2024
Clinical Implications of Inflammation in Patients With CirrhosisVictoria T Kronsten, Debbie L Shawcross
Expert Review of Gastroenterology & Hepatology|November 19, 2013
Recent insights into the pathogenesis of hepatic encephalopathy and treatmentsJonathan P Sturgeon, Debbie L Shawcross
Hepatology (Baltimore, Md.)|May 23, 2015
Salivary microbiota-immune profiling in cirrhosis: could this be the noninvasive strategy that will revolutionize prognostication in hepatology?Vishal C Patel, Debbie L Shawcross
Lancet (London, England)|July 27, 2010
The 6-month abstinence rule in liver transplantationDebbie L Shawcross, John G O'Grady
Hepatology (Baltimore, Md.)|January 7, 2022
The rise and fall and rise again of ammonia as a therapeutic target in HEThomas H Tranah, Debbie L Shawcross
Pageof 13